Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Roots Analysis | PRODUCT CODE: 1771300

Cover Image

PUBLISHER: Roots Analysis | PRODUCT CODE: 1771300

At Home Blood Collection Devices Market: Industry Trends and Global Forecasts - Distribution by Type of Blood Sample State, Method of Sample Collection, Device Usage, Area of Application, and Key Geographical Regions

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4799
PDF (One-Location Site License)
USD 6999
PDF (Department License)
USD 10599
PDF (Enterprise License)
USD 17999

Add to Cart

Description

Table of Contents

List of Tables

GLOBAL AT HOME BLOOD COLLECTION DEVICES: OVERVIEW

As per Roots Analysis, the global at home blood collection devices valued at USD 747 million in the current year is anticipated to grow at a CAGR of 10.7% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Blood Sample State

  • Dried Blood Sample
  • Liquid Blood Sample

Method of Sample Collection

  • Fingerstick Method
  • Push-Button Method

Device Usage

  • Single-use Devices
  • Reusable Devices

Area of Application

  • Diagnostics
  • Research
  • Therapeutics
  • Other Areas of Applications

Key Geographical Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa

GLOBAL AT HOME BLOOD COLLECTION DEVICES: GROWTH AND TRENDS

Notably, in the past, approaches used for blood collection were invasive, time consuming and required a healthcare expert. However, in recent years, the methods for blood collection at home have evolved at a rapid pace. In fact, according to a research study, 69% of participants indicated that they would more likely participate in clinical trials if they had the option to provide self-collected samples like self-blood collection. Consequently, the number of at home testing kits have increased in the last few years.

At Home Blood Collection Devices Market - IMG1

Further, in the COVID-19 era, the demand for point of care treatment had increased to support physical distancing and avoid risk of infections, thus leading to a decline in number of patients visiting laboratories for sample collection and testing. Consequently, it encouraged several stakeholders in the domain to develop novel devices and technologies that can enable patients to collect blood samples remotely at home. With the advancements in molecular detection techniques and a significant reduction in the amount of sample required for testing, miniature devices are transforming diagnostic and monitoring platforms toward point-of-care applications. This technique is well known for capturing minute samples of blood. Moreover, these techniques are more user friendly, as compared to traditional sampling techniques which are highly invasive and may show variation in analysis.

GLOBAL AT HOME BLOOD COLLECTION DEVICES: KEY INSIGHTS

The report delves into the current state of global at home blood collection devices and identifies potential growth opportunities within the industry. Some key findings from the report include:

  • Presently, close to 50 at-home blood collection and micro sampling devices are available / being developed; majority of the firms engaged in this domain are startups or small companies located in the US.
  • Most of the at-home devices intended for collection of whole capillary blood are presently marketed; DBS technology, used for preparation of dried blood spot cards, has emerged as the most popular platform.
  • Recently, TAP(R) II and Tasso-M20 self-blood collecting devices received CE mark approval from the European Commission.
  • Examples of companies offering all types of blood samples include (in alphabetical order) DBS System, Neoteryx, Sandstone Diagnostics and Sedia Biosciences.
  • In pursuit of gaining a competitive edge, stakeholders are actively expanding their product portfolios and upgrading their devices, via incorporation of advanced features.
  • The growing interest of the stakeholders is also reflected from the recent rise in partnership activity; a significant proportion of the deals inked till date were focused on market expansion.
At Home Blood Collection Devices Market - IMG2
  • Over the years, the intellectual property related to blood collection devices has grown at a commendable pace, with majority of the patents being filed by industry players.
  • Number of patents filed / granted in this domain have increased at a CAGR of 11%, with maximum number of patents filed / granted in 2019.
  • The high value patents focus on blood sample management, including systems and methods for sample collection, stabilization and preservation.
  • Most of the patents were filed / granted in North America; in this region, more than 90% patents were filed by the industry players.
  • To support the ongoing innovation in this domain, private and public investors have made substantial capital investments, worth ~USD 650 million, in initiatives undertaken by various industry stakeholders.
  • Funding and investment activity in this domain has increased at a CAGR of 12%. A significant proportion of the total investment was made in the last two years.
  • In addition to large players, several mid-sized and small companies have raised funds through IPO, venture capitals and other equity.
At Home Blood Collection Devices Market - IMG3
  • Given the favourable increase in adoption of at-home blood collection and micro sampling devices during the COVID-19 pandemic, the market is anticipated to witness significant growth in the foreseen future.

Example Players in the At Home Blood Collection Devices

  • EUROIMMUN
  • Everlywell
  • Labcorp
  • Labonovum
  • Lameditech
  • Quest Diagnostics
  • Spot On Sciences
  • Tasso
  • Weavr Health
  • YourBio Health

GLOBAL AT HOME BLOOD COLLECTION DEVICES: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global antiviral drugs market, focusing on key market segments, including [A] type of blood sample state, [B] method of sample collection, [C] device usage, [D] area of application and [E] key geographical regions.
  • Market Landscape: A comprehensive evaluation of at-home self-blood collection and micro sampling devices, considering various parameters, such as [A] device class, [B] current status of development, [C] regulatory approvals / certifications received, [D] type of technology, [E] device usage, [F] type of sample, [G] blood sample state, [H] volume of sample collected, [I] puncture site, [J] method of sample collection, [K] storage temperature and [L] application area. Additionally, a comprehensive evaluation of the companies engaged in the development of at home blood collection and micro sampling devices, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters and [D] most active players (in terms of number of devices).
  • Company Profiles: In-depth profiles of companies engaged in at home blood collection devices market, focusing on [A] company overviews, [B] product portfolio and [C] recent developments and an informed future outlook.
  • Product Competitiveness Analysis: A comprehensive competitive analysis of at home blood collection and micro sampling devices, examining factors, such as [A] supplier power and [B] key product-related specifications.
  • Patent Analysis: An in-depth analysis of patents filed / granted till date in the at home blood collection devices domain, based on various relevant parameters, such as [A] type of patent, [B] publication year, [C] application year, [D] regional applicability, [E] CPC symbols, [F] emerging focus areas, [G] most active players (in terms of the number of patents filed / granted) and [H] patent valuation.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the global at home blood collection devices market, based on several parameters, such as [A] year of partnership, [B] type of partnership model adopted, [C] focus area, [D] therapeutic area and [E] regional distribution.
  • Funding and Investments: An in-depth analysis of the fundings received by players in at home blood collection devices market, based on relevant parameters, such as [A] year of investment, [B] number of funding instances, [C] amount invested, [D] type of funding, [E] most active players (in terms of number of funding instances and amount raised), [F] most active investors (in terms of number of funding instances), [G] geographical distribution, [H] purpose of investment and [I] application area.
  • Cost Saving Analysis: A comprehensive analysis of cost saving potential associated with the use of at-home self-blood collection and micro sampling devices examining various factors.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older
Show more
Product Code: RA100301

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Overview of At-Home Blood Collection and Micro Sampling Devices
  • 3.3. Applications of Blood Sampling and Testing
    • 3.3.1. Complete Blood Count
    • 3.3.2. Basic Metabolic Panel
    • 3.3.3. Lipoprotein Panel
  • 3.4. Types of Blood Sampling
    • 3.4.1. Dried Blood Sampling
    • 3.4.2. Wet Blood Sampling
  • 3.5. Benefits of At-Home Blood Collection
  • 3.6. Methods Used for At-Home Blood Collection
    • 3.6.1. Fingerstick Method
    • 3.6.2. Press Button Method
    • 3.6.3. Heel-stick Method
  • 3.7. Types of At-Home Blood Collection and Micro Sampling Devices
    • 3.7.1. Dried Blood Spot Collection Kits
    • 3.7.2. Microtainer Tubes
  • 3.8. Future Perspectives

4. MARKET OVERVIEW

  • 4.1. Chapter Overview
  • 4.2. At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
    • 4.2.1. Analysis by Device Class
    • 4.2.2. Analysis by Current Status of Development
    • 4.2.3. Analysis by Regulatory Approvals / Certifications Received
    • 4.2.4. Analysis by Type of Technology
    • 4.2.5. Analysis by Device Usage
    • 4.2.6. Analysis by Type of Sample
    • 4.2.7. Analysis by Blood Sample State
    • 4.2.8. Analysis by Volume of Sample Collected
    • 4.2.9. Analysis by Puncture Site
    • 4.2.10. Analysis by Method of Sample Collection
    • 4.2.11. Analysis by Storage Temperature
    • 4.2.12. Analysis by Application Area
  • 4.3. At-Home Blood Collection and Micro Sampling Devices: List of Developers
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Geography
    • 4.3.4. Analysis by Year of Establishment, Company Size and Location of Headquarters
  • 4.4. Most Active Players: Analysis by Number of Products

5. PRODUCT COMPETITIVENESS ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Assumptions and Key Input Parameters
  • 5.3. Methodology
    • 5.3.1. Product Competitiveness Analysis: North America
    • 5.3.2. Product Competitiveness Analysis: Europe
    • 5.3.3. Product Competitiveness Analysis: Asia-Pacific

6. COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. EUROIMMUN
    • 6.2.1. Company Overview
    • 6.2.2. Product Portfolio
    • 6.2.3. Recent Developments and Future Outlook
  • 6.3. Everlywell
    • 6.3.1. Company Overview
    • 6.3.2. Product Portfolio
    • 6.3.3. Recent Developments and Future Outlook
  • 6.4. Labcorp
    • 6.4.1. Company Overview
    • 6.4.2. Product Portfolio
    • 6.4.3. Recent Developments and Future Outlook
  • 6.5. Labonovum
    • 6.5.1. Company Overview
    • 6.5.2. Product Portfolio
    • 6.5.3. Recent Developments and Future Outlook
  • 6.6. Lameditech
    • 6.6.1. Company Overview
    • 6.6.2. Product Portfolio
    • 6.6.3. Recent Developments and Future Outlook
  • 6.7. Quest Diagnostics
    • 6.7.1. Company Overview
    • 6.7.2. Product Portfolio
    • 6.7.3. Recent Developments and Future Outlook
  • 6.8. Spot On Sciences
    • 6.8.1. Company Overview
    • 6.8.2. Product Portfolio
    • 6.8.3. Recent Developments and Future Outlook
  • 6.9. Tasso
    • 6.9.1. Company Overview
    • 6.9.2. Product Portfolio
    • 6.9.3. Recent Developments and Future Outlook
  • 6.10. Weavr Health
    • 6.10.1. Company Overview
    • 6.10.2. Product Portfolio
    • 6.10.3. Recent Developments and Future Outlook
  • 6.11. YourBio Health
    • 6.11.1. Company Overview
    • 6.11.2. Product Portfolio
    • 6.11.3. Recent Developments and Future Outlook

7. PATENT ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
    • 7.2.1. Scope and Methodology
    • 7.2.2. Analysis by Publication Year
    • 7.2.3. Analysis by Publication Year and Type of Patent
    • 7.2.4. Analysis by Geography
    • 7.2.5. Analysis by CPC Symbols
    • 7.2.6. Analysis by Emerging Focus Area
    • 7.2.7. Most Active Players: Analysis by Number of Patents
    • 7.2.8. Patent Benchmarking Analysis
    • 7.2.9. Patent Valuation Analysis
    • 7.2.10. Overall Intellectual Property Portfolio: Analysis by Type of Organization

8. PARTNERSHIPS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Year and Type of Partnership
    • 8.3.4. Analysis by Focus Area
    • 8.3.5. Analysis by Year of Partnership and Focus Area
    • 8.3.6. Analysis by Type of Partnership and Focus Area
    • 8.3.7. Analysis by Therapeutic Area
    • 8.3.8. Analysis by Region
      • 8.3.8.1. Continent-wise Distribution
      • 8.3.8.2. Intercontinental and Intracontinental Distribution
      • 8.3.8.3. Country-wise Distribution
    • 8.3.9. Most Active Players: Analysis by Number of Partnerships

9. FUNDING AND INVESTMENT ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Types of Funding
  • 9.3. At-Home Blood Collection and Micro Sampling Devices: Funding and Investment Analysis
    • 9.3.1. Analysis of Number of Funding Instances by Year
    • 9.3.2. Analysis by Amount Invested
    • 9.3.3. Analysis by Type of Funding
    • 9.3.4. Analysis by Year and Type of Funding
    • 9.3.5. Analysis of Amount Invested by Geography
    • 9.3.6. Most Active Players: Analysis by Number of Funding Instances and Amount Invested
    • 9.3.7. Key Investors: Analysis by Number of Funding Instances
    • 9.3.8. Analysis by Purpose of Investment
    • 9.3.9. Analysis by Application Area
  • 9.4. Concluding Remarks

10. COST SAVING ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Key Assumptions
  • 10.3. Methodology
  • 10.4. Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices
  • 10.5. Concluding Remarks

11. MARKET FORECAST

  • 11.1. Chapter Overview
  • 11.2. Forecast Methodology and Assumptions
  • 11.3. Global At-Home Blood Collection and Micro Sampling Devices Market, Till 2035
    • 11.3.1. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Blood Sample State
      • 11.3.1.1. At-Home Blood Collection and Micro Sampling Devices Market for Dried Blood Samples, Till 2035
      • 11.3.1.2. At-Home Blood Collection and Micro Sampling Devices Market for Liquid Blood Samples, Till 2035
    • 11.3.2. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Method of Sample Collection
      • 11.3.2.1. At-Home Blood Collection and Micro Sampling Devices Market for Fingerstick Method of Sample Collection, Till 2035
      • 11.3.2.2. At-Home Blood Collection and Micro Sampling Devices Market for Push-Button Method of Sample Collection, Till 2035
    • 11.3.3. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Device Usage
      • 11.3.3.1. At-Home Blood Collection and Micro Sampling Devices Market for Single-use Devices, Till 2035
      • 11.3.3.2. At-Home Blood Collection and Micro Sampling Devices Market for Reusable Devices, Till 2035
    • 11.3.4. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Area of Application
      • 11.3.4.1. At-Home Blood Collection and Micro Sampling Device Market for Diagnostics, Till 2035
      • 11.3.4.2. At-Home Blood Collection and Micro Sampling Device Market for Research, Till 2035
      • 11.3.4.3. At-Home Blood Collection and Micro Sampling Device Market for Therapeutics, Till 2035
      • 11.3.4.4. At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, Till 2035
    • 11.3.5. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Region
      • 11.3.5.1. At-Home Blood Collection and Micro Sampling Devices Market in North America, Till 2035
      • 11.3.5.2. At-Home Blood Collection and Micro Sampling Devices Market in Europe, Till 2035
      • 11.3.5.3. At-Home Blood Collection and Micro Sampling Devices Market in Asia-Pacific, Till 2035
      • 11.3.5.4. At-Home Blood Collection and Micro Sampling Devices Market in Latin America, Till 2035
      • 11.3.5.5. At-Home Blood Collection and Micro Sampling Devices Market in MENA, Till 2035

12. CONCLUSION

13. EXECUTIVE INSIGHTS

  • 13.1. Chapter Overview
  • 13.2. Interview Transcript, Business Development Manager, Company A

14. APPENDIX I: TABULATED DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

Show more
Product Code: RA100301

List of Tables

  • Table 3.1 Various Applications of Complete Blood Count Test
  • Table 3.2 Various Applications of Basic Metabolic Panel
  • Table 3.3 Various Applications of Lipoprotein Panel
  • Table 4.1 At-Home Blood Collection and Micro Sampling Devices: Current Market Landscape
  • Table 4.2 At-Home Blood Collection and Micro Sampling Devices: Information on Devices
  • Table 4.3 At-Home Blood Collection and Micro Sampling Devices: Information on Samples Collected
  • Table 4.4 At-Home Blood Collection and Micro Sampling Devices: Information on Type of Technology and Application Area
  • Table 4.5 At-Home Blood Collection and Micro Sampling Devices: List of Developers
  • Table 6.1 EUROIMMUN: Company Overview
  • Table 6.2 EUROIMMUN: Product Portfolio
  • Table 6.3 Everlywell: Company Overview
  • Table 6.4 Everlywell: Product Portfolio
  • Table 6.5 Everlywell: Recent Developments and Future Outlook
  • Table 6.6 Labcorp: Company Overview
  • Table 6.7 Labcorp: Product Portfolio
  • Table 6.8 Labonovum: Company Overview
  • Table 6.9 Labonovum: Product Portfolio
  • Table 6.10 Lameditech: Company Overview
  • Table 6.11 Lameditech: Product Portfolio
  • Table 6.12 Quest Diagnostics: Company Overview
  • Table 6.13 Quest Diagnostics: Product Portfolio
  • Table 6.14 Spot on Sciences: Company Overview
  • Table 6.15 Spot on Sciences: Product Portfolio
  • Table 6.16 Spot on Science: Recent Developments and Future Outlook
  • Table 6.17 Tasso: Company Overview
  • Table 6.18 Tasso: Product Portfolio
  • Table 6.19 Tasso: Recent Developments and Future Outlook
  • Table 6.20 Weavr Health: Company Overview
  • Table 6.21 Weavr Health: Product Portfolio
  • Table 6.22 Weavr Health: Recent Developments and Future Outlook
  • Table 6.23 YourBio Health: Company Overview
  • Table 6.24 YourBio Health: Product Portfolio
  • Table 7.1 Patent Analysis: List of Top CPC Symbols
  • Table 7.2 Patent Analysis: Summary of Benchmarking Analysis
  • Table 7.3 Patent Analysis: Various Categorizations based on Weighted Valuation Scores
  • Table 7.4 Patent Analysis: List of Leading Patents (In Terms of Highest Relative Valuation)
  • Table 8.1 At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
  • Table 8.2 Partnerships: Information on Focus Area and Therapeutic Area
  • Table 9.1 At-Home Blood Collection and Micro Sampling Device Market: Funding and Investments, Since 2013
  • Table 9.2 Funding and Investment Analysis: Summary of Investments
  • Table 9.3 Funding and Investment Analysis: Summary of Venture Capital Funding
  • Table 9.4 At-Home Blood Collection and Micro Sampling Device Market: Information on Purpose of Funding and Area of Application, Since 2013
  • Table 14.1 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Class
  • Table 14.2 At-Home Blood Collection and Micro Sampling Devices: Distribution by Current Status of Development
  • Table 14.3 At-Home Blood Collection and Micro Sampling Devices: Distribution by Regulatory Approvals / Certifications Received
  • Table 14.4 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Technology
  • Table 14.5 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Usage
  • Table 14.6 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Sample
  • Table 14.7 At-Home Blood Collection and Micro Sampling Devices: Distribution by Blood Sample State
  • Table 14.8 At-Home Blood Collection and Micro Sampling Devices: Distribution by Volume of Sample Collected
  • Table 14.9 At-Home Blood Collection and Micro Sampling Devices: Distribution by Puncture Site
  • Table 14.10 At-Home Blood Collection and Micro Sampling Devices: Distribution by Method of Sample Collection
  • Table 14.11 At-Home Blood Collection and Micro Sampling Devices: Distribution by Storage Temperature
  • Table 14.12 At-Home Blood Collection and Micro Sampling Devices: Distribution by Application Area
  • Table 14.13 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment
  • Table 14.14 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Company Size
  • Table 14.15 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Continent-wise)
  • Table 14.16 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Country-wise)
  • Table 14.17 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment, Company Size and Location of Headquarters
  • Table 14.18 Most Active Players: Distribution by Number of Products
  • Table 14.19 Most Active Players: Distribution by Current Status of Development
  • Table 14.20 Patent Analysis: Distribution by Type of Patent
  • Table 14.21 Patent Analysis: Cumulative Distribution by Publication Year, Since 2015
  • Table 14.22 Patent Analysis: Distribution by Type of Patent and Publication Year
  • Table 14.23 Patent Analysis: Distribution by Geography
  • Table 14.24 Patent Analysis: North America Scenario
  • Table 14.25 Patent Analysis: Asia-Pacific Scenario
  • Table 14.26 Most Active Players: Distribution by Number of Patents
  • Table 14.27 Patent Analysis: Distribution by Patent Age
  • Table 14.28 Overall Intellectual Property Portfolio: Distribution by Type of Organization
  • Table 14.29 Partnerships: Cumulative Year-wise Trend, Since 2016
  • Table 14.30 Partnerships: Distribution by Type of Partnership
  • Table 14.31 Partnerships: Distribution by Year and Type of Partnership
  • Table 14.32 Partnerships: Distribution by Focus Area
  • Table 14.33 Partnerships: Distribution by Type of Partnership and Focus Area
  • Table 14.34 Partnerships: Distribution by Therapeutic Area
  • Table 14.35 Partnerships: Continent-wise Distribution
  • Table 14.36 Partnerships: Country-wise Distribution
  • Table 14.37 Most Active Players: Distribution by Number of Partnerships
  • Table 14.38 Funding and Investment Analysis: Cumulative Year-wise Distribution of Number of Instances, Since 2013
  • Table 14.39 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, Since 2013 (USD Million)
  • Table 14.40 Funding and Investment Analysis: Distribution by Type of Funding, Since 2013
  • Table 14.41 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding, Since 2013 (USD Million)
  • Table 14.42 Funding and Investment Analysis: Distribution by Year and Type of Funding, Since 2013
  • Table 14.43 Funding and Investment Analysis: Summary of Investments, Since 2013 (USD Million)
  • Table 14.44 Funding and Investment Analysis: Distribution by Geography
  • Table 14.45 Funding and Investment Analysis: Regional Distribution of Funding Instances
  • Table 14.46 Most Active Players: Distribution by Number of Funding Instances
  • Table 14.47 Most Active Players: Distribution by Amount Invested
  • Table 14.48 Funding and Investment Analysis: Distribution by Type of Investor
  • Table 14.49 Key Investors: Distribution by Number of Funding Instances
  • Table 14.50 Funding and Investment Analysis: Distribution by Purpose of Investment
  • Table 14.51 Funding and Investment Analysis: Distribution by Application Area
  • Table 14.52 Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices, Till 2035 (USD Million)
  • Table 14.53 Global At-Home Blood Collection and Micro Sampling Device Market, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.54 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Blood Sample State, Till 2035 (USD Million)
  • Table 14.55 At-Home Blood Collection and Micro Sampling Device Market for Dried Blood Samples, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.56 At-Home Blood Collection and Micro Sampling Device Market for Liquid Blood Samples, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.57 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Method of Sample Collection, Till 2035 (USD Million)
  • Table 14.58 At-Home Blood Collection and Micro Sampling Device Market for Fingerstick Method of Sample Collection, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.59 At-Home Blood Collection and Micro Sampling Device Market for Push-Button Method of Sample Collection, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.60 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Device Usage, Till 2035 (USD Million)
  • Table 14.61 At-Home Blood Collection and Micro Sampling Device Market for Single-use Devices, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.62 At-Home Blood Collection and Micro Sampling Device Market for Reusable Devices, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.63 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Areas of Application, Till 2035 (USD Million)
  • Table 14.64 At-Home Blood Collection and Micro Sampling Device Market for Diagnostics Purposes, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.65 At-Home Blood Collection and Micro Sampling Device Market for Research Purposes, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.66 At-Home Blood Collection and Micro Sampling Device Market for Therapeutics Purposes, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.67 At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.68 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Region, Till 2035 (USD Million)
  • Table 14.69 At-Home Blood Collection and Micro Sampling Device Market in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.70 At-Home Blood Collection and Micro Sampling Device Market in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.71 At-Home Blood Collection and Micro Sampling Device Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.72 At-Home Blood Collection and Micro Sampling Device Market in Latin America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.73 At-Home Blood Collection and Micro Sampling Device Market in MENA, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)

List of Figures

  • Figure 2.1 Executive Summary: Current Market Landscape
  • Figure 2.2 Executive Summary: Product Competitiveness Analysis
  • Figure 2.3 Executive Summary: Patent Analysis
  • Figure 2.4 Executive Summary: Partnerships and Collaborations
  • Figure 2.5 Executive Summary: Funding and Investment Analysis
  • Figure 2.6 Executive Summary: Cost Saving Analysis
  • Figure 2.7 Executive Summary: Market Sizing and Opportunity Analysis
  • Figure 3.1 Process of Sampling Dried Blood
  • Figure 4.1 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Class
  • Figure 4.2 At-Home Blood Collection and Micro Sampling Devices: Distribution by Current Status of Development
  • Figure 4.3 At-Home Blood Collection and Micro Sampling Devices: Distribution by Regulatory Approvals / Certifications Received
  • Figure 4.4 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Technology
  • Figure 4.5 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Usage
  • Figure 4.6 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Sample
  • Figure 4.7 At-Home Blood Collection and Micro Sampling Devices: Distribution by Blood Sample State
  • Figure 4.8 At-Home Blood Collection and Micro Sampling Devices: Distribution by Volume of Sample Collected
  • Figure 4.9 At-Home Blood Collection and Micro Sampling Devices: Distribution by Puncture Site
  • Figure 4.10 At-Home Blood Collection and Micro Sampling Devices: Distribution by Method of Sample Collection
  • Figure 4.11 At-Home Blood Collection and Micro Sampling Devices: Distribution by Storage Temperature
  • Figure 4.12 At-Home Blood Collection and Micro Sampling Devices: Distribution by Application Area
  • Figure 4.13 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment
  • Figure 4.14 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Company Size
  • Figure 4.15 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Continent-wise)
  • Figure 4.16 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Country-wise)
  • Figure 4.17 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment, Company Size and Location of Headquarters
  • Figure 4.18 Most Active Players: Distribution by Number of Products
  • Figure 4.19 Most Active Players: Distribution by Current Status of Development
  • Figure 5.1 Product Competitiveness Analysis: North America Scenario
  • Figure 5.2 Product Competitiveness Analysis: Europe Scenario
  • Figure 5.3 Product Competitiveness Analysis: Asia-Pacific Scenario
  • Figure 7.1 Patent Analysis: Distribution by Type of Patent
  • Figure 7.2 Patent Analysis: Cumulative Distribution by Publication Year, Since 2015
  • Figure 7.3 Patent Analysis: Distribution by Type of Patent and Publication Year
  • Figure 7.4 Patent Analysis: Distribution by Geography
  • Figure 7.5 Patent Analysis: North America Scenario
  • Figure 7.6 Patent Analysis: Asia-Pacific Scenario
  • Figure 7.7 Patent Analysis: Distribution by CPC Symbols
  • Figure 7.8 Patent Analysis: Distribution by Emerging Focus Area
  • Figure 7.9 Most Active Players: Distribution by Number of Patents
  • Figure 7.10 Patent Benchmarking Analysis: Your Bio Health and Becton Dickinson
  • Figure 7.11 Patent Benchmarking Analysis: Other Leading Players
  • Figure 7.12 Patent Portfolio: Distribution by Patent Age
  • Figure 7.13 Patent Valuation Analysis
  • Figure 7.14 Overall Intellectual Property Portfolio: Distribution by Type of Organization
  • Figure 8.1 Partnerships: Cumulative Year-wise Trend, Since 2016
  • Figure 8.2 Partnerships: Distribution by Type of Partnership
  • Figure 8.3 Partnerships: Distribution by Year and Type of Partnership
  • Figure 8.4 Partnerships: Distribution by Focus Area
  • Figure 8.5 Partnerships: Distribution by Year of Partnership and Focus Area
  • Figure 8.6 Heat Map: Distribution by Type of Partnership and Focus Area
  • Figure 8.7 Partnerships: Distribution by Therapeutic Area
  • Figure 8.8 Partnerships: Continent-wise Distribution
  • Figure 8.9 Partnerships: Intercontinental and Intracontinental Agreements
  • Figure 8.10 Partnerships: Country-wise Distribution
  • Figure 8.11 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Number of Instances, Since 2013
  • Figure 9.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, Since 2013 (USD Million)
  • Figure 9.3 Funding and Investment Analysis: Distribution by Type of Funding, Since 2013
  • Figure 9.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding, Since 2013 (USD Million)
  • Figure 9.5 Funding and Investment Analysis: Distribution by Year and Type of Funding, Since 2013
  • Figure 9.6 Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested, Since 2013 (USD Million)
  • Figure 9.7 Funding and Investment Analysis: Summary of Investments, Since 2013 (USD Million)
  • Figure 9.8 Funding and Investment Analysis: Distribution by Geography
  • Figure 9.9 Funding and Investment Analysis: Regional Distribution of Funding Instances
  • Figure 9.10 Most Active Players: Distribution by Number of Funding Instances
  • Figure 9.11 Most Active Players: Distribution by Amount Invested
  • Figure 9.12 Funding and Investment Analysis: Distribution by Type of Investor
  • Figure 9.13 Key Investors: Distribution by Number of Funding Instances
  • Figure 9.14 Funding and Investment Analysis: Distribution by Purpose of Investment
  • Figure 9.15 Funding and Investment Analysis: Distribution by Application Area
  • Figure 10.1 Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices, Till 2035 (USD Million)
  • Figure 11.1 Global At-Home Blood Collection and Micro Sampling Device Market, Till 2035 (USD Million)
  • Figure 11.2 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Blood Sample State, Till 2035 (USD Million)
  • Figure 11.3 At-Home Blood Collection and Micro Sampling Device Market for Dried Blood Samples, Till 2035 (USD Million)
  • Figure 11.4 At-Home Blood Collection and Micro Sampling Device Market for Liquid Blood Samples, Till 2035 (USD Million)
  • Figure 11.5 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Method of Sample Collection, Till 2035 (USD Million)
  • Figure 11.6 At-Home Blood Collection and Micro Sampling Device Market for Fingerstick Method of Sample Collection, Till 2035 (USD Million)
  • Figure 11.7 At-Home Blood Collection and Micro Sampling Device Market for Push-Button Method of Sample Collection, Till 2035 (USD Million)
  • Figure 11.8 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Device Usage, Till 2035 (USD Million)
  • Figure 11.9 At-Home Blood Collection and Micro Sampling Device Market for Single-use Devices, Till 2035 (USD Million)
  • Figure 11.10 At-Home Blood Collection and Micro Sampling Device Market for Reusable Devices, Till 2035 (USD Million)
  • Figure 11.11 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Areas of Application, Till 2035 (USD Million)
  • Figure 11.12 At-Home Blood Collection and Micro Sampling Device Market for Diagnostic Purposes, Till 2035 (USD Million)
  • Figure 11.13 At-Home Blood Collection and Micro Sampling Device Market for Research Purposes, Till 2035 (USD Million)
  • Figure 11.14 At-Home Blood Collection and Micro Sampling Device Market for Therapeutic Purposes, Till 2035 (USD Million)
  • Figure 11.15 At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, Till 2035 (USD Million)
  • Figure 11.16 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Region, Till 2035 (USD Million)
  • Figure 11.17 At-Home Blood Collection and Micro Sampling Device Market in North America, Till 2035 (USD Million)
  • Figure 11.18 At-Home Blood Collection and Micro Sampling Device Market in Europe, Till 2035 (USD Million)
  • Figure 11.19 At-Home Blood Collection and Micro Sampling Device Market in Asia-Pacific, Till 2035 (USD Million)
  • Figure 11.20 At-Home Blood Collection and Micro Sampling Device Market in Latin America, Till 2035 (USD Million)
  • Figure 11.21 At-Home Blood Collection and Micro Sampling Device Market in MENA, Till 2035 (USD Million)
  • Figure 12.1 Concluding Remarks: Current Market Landscape
  • Figure 12.2 Concluding Remarks: Product Competitiveness Analysis
  • Figure 12.3 Concluding Remarks: Patent Analysis
  • Figure 12.4 Concluding Remarks: Partnerships and Collaborations
  • Figure 12.5 Concluding Remarks: Funding and Investment Analysis
  • Figure 12.6 Concluding Remarks: Market Sizing and Opportunity Analysis
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!